Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 1261-1280 of 2,724 trials

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

NCT04688671

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of ETX 018810 in Subjects with Diabetic Peripheral Neuropathic Pain.

Diabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathy

Eliem Therapeutics (UK) Ltd.167 participantsStarted Nov 2020

Mobile, Alabama, United States • Phoenix, Arizona, United States • Fresno, California, United States +19 more locations

TERMINATEDPhase 3< 1 mile

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

NCT01849874

The MILO Study (MEK Inhibitor in Low-grade Serous Ovarian Cancer) is a Phase 3 study during which patients with recurrent or persistent low-grade serous (LGS) carcinomas of the ovary, fallopian tube or primary peritoneum will receive either investigational study drug MEK162 or a chemotherapy chosen by the physician (liposomal doxorubicin, paclitaxel or topotecan). Patients will be followed to compare the effectiveness of the study drug to that of the selected chemotherapies. Patients may be eligible to crossover from physician's choice chemotherapy to MEK162 if they meet certain inclusion criteria including centrally confirmed disease progression. Approximately 360 patients from North America, Europe and Australia will be enrolled in this study.

Low-grade Serous Ovarian CancerLow-grade Serous Fallopian Tube CancerLow-grade Serous Peritoneal Cancer

Pfizer341 participantsStarted Jun 2013

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +223 more locations

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Rheumatoid Arthritis Trials in Other Cities

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

FX Shoulder Solutions Retrospective / Prospective Clinical Study

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma

A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration

Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis

Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.

The Chocolate Touch Study

In-Stent Restenosis Post-Approval Study

Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial

Other Conditions in Phoenix